Tiny dose, big data: healthy volunteers help map RE104's journey through the body
NCT ID NCT07146191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a single tiny dose of RE104 moves through and leaves the body in 8 healthy adults. Researchers measured the drug and its breakdown products in blood, urine, and stool over at least a week. The goal was purely to understand absorption and elimination, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PPD Inc.
Austin, Texas, 78744, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.